TD SYNNEX Total Cost of Revenue decreased by 1.7% to $15.91B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.6%, from $13.53B to $15.91B. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 18.3% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.53B | $4.89B | $14.67B | $14.50B | $14.31B | $14.44B | $15.19B | $14.12B | $13.10B | $12.99B | $13.39B | $12.97B | $12.97B | $13.72B | $14.80B | $13.53B | $13.90B | $14.52B | $16.18B | $15.91B |
| QoQ Change | — | -11.5% | +199.7% | -1.1% | -1.3% | +0.9% | +5.2% | -7.0% | -7.2% | -0.8% | +3.1% | -3.1% | +0.0% | +5.8% | +7.9% | -8.6% | +2.7% | +4.5% | +11.5% | -1.7% |
| YoY Change | — | — | — | — | +159.0% | +195.0% | +3.5% | -2.6% | -8.5% | -10.0% | -11.8% | -8.2% | -0.9% | +5.7% | +10.6% | +4.4% | +7.1% | +5.8% | +9.3% | +17.6% |